A Phase 3, Open-Label Study of the Safety, Efficacy, and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson's Disease Patients with Unsatisfactory Control on Available Therapy.
To assess the long-term safety of apomorphine continuous infusion in advanced Parkinson?s disease (PD) patients who are unable to achieve adequate motor control despite optimal treatment with noninvasive therapy.
This Study is
No Longer Enrolling
Adult
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Treatment
University of Colorado Hospital
Protocol Number: 15-1274
More information available at ClinicalTrials.gov: NCT02339064
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers